Methylene Blue is unique among pharmaceuticals in directly targeting mitochonrial dysfunction- a core pathology in chronic disease and aging.
Mechanisms in Mitochondrial Optimization
- Increase ATP output
- Reduces mitochondrial ROS production
- Improves membrance potential
- Protects mitochonrial DNA from oxidative damage
- Attenuates proinflammatory signaling cascades triggered by dysfunctional mitochondria
Clinical Outcomes observed
- Improved cognitive performance and neuroplasticity, can be used in Alzheimers disease , parkinsons disease , cognitive decline , long covid "brain fog"
- Enchanced cellular energy in chronic fatigue and fibromyalgia
- Better cardiovascular effciency and vasoregulation
- Antimicrobial effects